Matches in SemOpenAlex for { <https://semopenalex.org/work/W80432145> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W80432145 endingPage "63" @default.
- W80432145 startingPage "353" @default.
- W80432145 abstract "A sustained response (SR) to interferon (IFN) is only observed in 15-20% of patients with chronic hepatitis C (CHC). The aim of this study was to determine the long-term effectiveness and safety of the treatment with IFN plus ribavirin (RIB) over two years in CHC patients without SR to IFN.A prospective and open longitudinal follow-up study was conducted over 3 years.A total of 77 CHC patients were included: 63 non-responders (NR) and 14 relapsers (R) to IFN. Patients were treated with IFN (3 MU s.c. three times a week) and RIB (1,000-1,200 mg p.o. daily) for 12 months. Treatment tolerance and viral response (HCV-RNA in serum < 1,000 copies/ml) were assessed after 1, 3, 6 and 12 months of treatment. SR and relapsing rates were subsequently evaluated 6, 12 and 24 months after the end of the treatment, together with those variables capable of predicting SR.At the end of the treatment, 19/77 patients responded (24.7%), 9/63 (14.3%) were non-responders and 10/14 (71.4%) relapsers, and these same patients exhibited SR after 6 months. The SR rate two years after treatment was 22.1% [8/63 (12.7%) NR and 9/14 (64.3%) R]. The relapse rate after 6 months and two years was respectively 0 and 10.5% (2/77). Independent variables capable of predicting SR were negative viremia conversion within the first month of treatment, maintenance of such negative viremia after 6 months, and R status to IFN. Side effects were recorded in 90.9% of cases (70/77), the most frequent being pseudoinfluenza syndrome. Treatment had to be discontinued in 33.8% of patients (26/77).Combined IFN-RIB therapy for 12 months in CHC patients without SR to IFN obtains a long-term SR of 22.1%, this rate being higher in relapsers to prior IFN therapy (64.3% in R versus 12.7% in NR)." @default.
- W80432145 created "2016-06-24" @default.
- W80432145 creator A5005640639 @default.
- W80432145 creator A5007748575 @default.
- W80432145 creator A5009040414 @default.
- W80432145 creator A5014064708 @default.
- W80432145 creator A5026171906 @default.
- W80432145 creator A5026814211 @default.
- W80432145 creator A5061689613 @default.
- W80432145 creator A5081979817 @default.
- W80432145 date "2001-06-01" @default.
- W80432145 modified "2023-10-18" @default.
- W80432145 title "Long-term response to interferon plus ribavirin in patients with chronic hepatitis C refractory to interferon." @default.
- W80432145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11482039" @default.
- W80432145 hasPublicationYear "2001" @default.
- W80432145 type Work @default.
- W80432145 sameAs 80432145 @default.
- W80432145 citedByCount "3" @default.
- W80432145 countsByYear W804321452016 @default.
- W80432145 crossrefType "journal-article" @default.
- W80432145 hasAuthorship W80432145A5005640639 @default.
- W80432145 hasAuthorship W80432145A5007748575 @default.
- W80432145 hasAuthorship W80432145A5009040414 @default.
- W80432145 hasAuthorship W80432145A5014064708 @default.
- W80432145 hasAuthorship W80432145A5026171906 @default.
- W80432145 hasAuthorship W80432145A5026814211 @default.
- W80432145 hasAuthorship W80432145A5061689613 @default.
- W80432145 hasAuthorship W80432145A5081979817 @default.
- W80432145 hasConcept C121332964 @default.
- W80432145 hasConcept C126322002 @default.
- W80432145 hasConcept C142424586 @default.
- W80432145 hasConcept C203014093 @default.
- W80432145 hasConcept C2522874641 @default.
- W80432145 hasConcept C2776178377 @default.
- W80432145 hasConcept C2776185481 @default.
- W80432145 hasConcept C2776455275 @default.
- W80432145 hasConcept C2780040827 @default.
- W80432145 hasConcept C3020491458 @default.
- W80432145 hasConcept C71924100 @default.
- W80432145 hasConcept C87355193 @default.
- W80432145 hasConcept C90924648 @default.
- W80432145 hasConceptScore W80432145C121332964 @default.
- W80432145 hasConceptScore W80432145C126322002 @default.
- W80432145 hasConceptScore W80432145C142424586 @default.
- W80432145 hasConceptScore W80432145C203014093 @default.
- W80432145 hasConceptScore W80432145C2522874641 @default.
- W80432145 hasConceptScore W80432145C2776178377 @default.
- W80432145 hasConceptScore W80432145C2776185481 @default.
- W80432145 hasConceptScore W80432145C2776455275 @default.
- W80432145 hasConceptScore W80432145C2780040827 @default.
- W80432145 hasConceptScore W80432145C3020491458 @default.
- W80432145 hasConceptScore W80432145C71924100 @default.
- W80432145 hasConceptScore W80432145C87355193 @default.
- W80432145 hasConceptScore W80432145C90924648 @default.
- W80432145 hasIssue "6" @default.
- W80432145 hasLocation W804321451 @default.
- W80432145 hasOpenAccess W80432145 @default.
- W80432145 hasPrimaryLocation W804321451 @default.
- W80432145 hasRelatedWork W1524725311 @default.
- W80432145 hasRelatedWork W158907189 @default.
- W80432145 hasRelatedWork W1989042235 @default.
- W80432145 hasRelatedWork W2014171438 @default.
- W80432145 hasRelatedWork W2143125362 @default.
- W80432145 hasRelatedWork W2341829866 @default.
- W80432145 hasRelatedWork W2374920454 @default.
- W80432145 hasRelatedWork W2462498398 @default.
- W80432145 hasRelatedWork W2560320881 @default.
- W80432145 hasRelatedWork W80432145 @default.
- W80432145 hasVolume "93" @default.
- W80432145 isParatext "false" @default.
- W80432145 isRetracted "false" @default.
- W80432145 magId "80432145" @default.
- W80432145 workType "article" @default.